Eribulin in advanced breast cancer: safety, efficacy and new perspectives

被引：9
|
作者：
Garrone, Ornella [1 ]
Miraglio, Emanuela [1 ]
Vandone, Anna Maria [1 ]
Vanella, Paola [1 ]
Lingua, Daniele [1 ]
Merlano, Marco C. [1 ]
机构：
[1] Med Oncol AOS Croce & Carle Osped Insegnamento, Cuneo, Italy
来源：
FUTURE ONCOLOGY | 2017年 / 13卷 / 30期
关键词：
chemotherapy; eribulin; mechanism of action; metastatic breast cancer; new treatment; HALICHONDRIN-B ANALOG; ADVANCED SOLID TUMORS; PHASE-I; LOCALLY RECURRENT; 1ST-LINE THERAPY; CONSORTIUM TRIAL; DOSE-ESCALATION; POOLED ANALYSIS; MESYLATE E7389; CHEMOTHERAPY;
D O I：
10.2217/fon-2017-0283
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
Eribulin is a synthetic analog of halichondrin B belonging to microtubule-targeted agents with a distinct mechanism of inhibition of microtubule dynamics. This molecule has multiple nonmitotic effects on tumor biology, exhibiting effects on epithelial-mesenchimal transition and tumor vasculature. We review here preclinical and clinical studies on eribulin. The mitotic and nonmitotic effects together with its favorable safety profile make eribulin a unique drug with high potential in the treatment of metastatic breast cancer. The new emphasis of eribulin mechanism of action on vascular remodeling, microenvironment modifications and reversal of epithelial-mesenchimal transition paves the way to rethinking the use of the drug in an immunological perspective.
引用
收藏
页码：2759 / 2769
页数：11
相关论文
共 50 条
  • [21] Safety and efficacy of eribulin for "real-world" older patients with metastatic breast cancer
    de Nonneville, Alexandre
    Sabatier, Renaud
    Goncalves, Anthony
    Extra, Jean-Marc
    Tarpin, Carole
    Launay, Simon
    Tassy, Louis
    Viens, Patrice
    Rousseau, Frederique
    JOURNAL OF GERIATRIC ONCOLOGY, 2018, 9 (03) : 281 - 283
  • [22] POPULATION PHARMACOKINETIC-PHARMACODYNAMIC (PK/PD) ANALYSIS OF SAFETY AND EFFICACY OF ERIBULIN IN METASTATIC OR LOCALLY ADVANCED BREAST CANCER PATIENTS
    Gupta, A.
    Mould, D. R.
    Reyderman, L.
    Wanders, J.
    Shuster, D. E.
    Hussein, Z.
    Jansen, M.
    ANNALS OF ONCOLOGY, 2010, 21 : 111 - 111
  • [23] Efficacy and safety of eribulin mesylate in advanced soft tissue sarcomas
    Noujaim, Jonathan
    Alam, Salma
    Thway, Khin
    Jones, Robin Lewis
    INDIAN JOURNAL OF MEDICAL AND PAEDIATRIC ONCOLOGY, 2016, 37 (03) : 125 - 130
  • [24] Retrospective analysis of the efficacy and safety of eribulin therapy for metastatic breast cancer in daily practice
    Tanaka, Toshihiro
    Ueno, Miho
    Nakashima, Yuta
    Chinen, Shotaro
    Sato, Eiichi
    Masaki, Michio
    Mogi, Ai
    Sasaki, Hidenori
    Tamura, Kazuo
    Takamatsu, Yasushi
    THORACIC CANCER, 2017, 8 (05) : 523 - 529
  • [25] Efficacy and safety of eribulin-based chemotherapy in patients with advanced breast cancer: A single-centre retrospective study.
    Li, Yuting
    Han, Dan
    Hu, Ting
    Xiong, Jie
    Zhao, Yanxia
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [26] Efficacy and Safety of Nedaplatin in Advanced Breast Cancer Therapy
    Pang, Hui
    Feng, Ting
    Lu, Hailing
    Meng, Qingwei
    Chen, Xuesong
    Shen, Qiang
    Dong, Xiaoqun
    Cai, Li
    CANCER INVESTIGATION, 2016, 34 (04) : 167 - 172
  • [27] Efficacy and safety of oral vinorelbine in advanced breast cancer
    Silva, S.
    Winter, M. C.
    Din, O. S.
    EUROPEAN JOURNAL OF CANCER, 2014, 50 : S184 - S184
  • [28] Real-world efficacy and safety of eribulin in advanced and pretreated HER2-negative breast cancer in a Spanish comprehensive cancer center
    Milana Bergamino Sirvén
    Adela Fernández-Ortega
    Agostina Stradella
    Idoia Morilla
    Catalina Falo
    Silvia Vázquez
    Roser Castany
    Rafael Villanueva
    Sabela Recalde
    Valentí Navarro Pérez
    Miguel Gil-Gil
    Sonia Pernas
    BMC Pharmacology and Toxicology, 20
  • [29] Real-world efficacy and safety of eribulin in advanced and pretreated HER2-negative breast cancer in a Spanish comprehensive cancer center
    Bergamino Sirven, Milana
    Fernandez-Ortega, Adela
    Stradella, Agostina
    Morilla, Idoia
    Falo, Catalina
    Vazquez, Silvia
    Castany, Roser
    Villanueva, Rafael
    Recalde, Sabela
    Navarro Perez, Valenti
    Gil-Gil, Miguel
    Pernas, Sonia
    BMC PHARMACOLOGY & TOXICOLOGY, 2019, 20 (01):
  • [30] ERIBULIN INDUCED ENCEPHALOPATHY IN A PATIENT WITH ADVANCED BREAST CANCER
    Shredi, A.
    Elgwairi, E.
    Abdalla, A.
    El Nawaa, S.
    Bedanie, G. D.
    Elmassry, M.
    Zitun, M.
    Nugent, K.
    JOURNAL OF INVESTIGATIVE MEDICINE, 2020, 68 (02) : 509 - 510
12345